EPYSQLI, a biosimilar referencing Soliris1 (eculizumab), is Samsung Bioepis' first biosimilar in hematology to be recommended for marketing authorization by the European Medicines Agency INCHEON, Korea
GUANGZHOU, China, March 31, 2023 /PRNewswire/ On March 28th, the China International Furniture Fair (CIFF 2023) kicked off at the Guangzhou Import and Export Fair Complex. At the event, JIECANG
Nasdaq Copenhagen has today given the below observation status: ISIN Name DK0061540770 DONKEYREPUBLIC HOLDING The company has been given observations status because the annual
BANGALORE, India, March 31, 2023 /PRNewswire/ The Global Biologics CDMO Market is Segmented by Type (Biological Agent, Biosimilar Drug), by Application (Cell Therapy, Drug Development): Global